Effectiveness of bronchial thermoplasty in patients with severe refractory asthma: Clinical and histopathologic correlations

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 4, 2017, Pages 1176-1185

  Pretolani, Marina ^a,b,c   Bergqvist, Anders ^d   Thabut, Gabriel ^a,b,c,d,e,f   Dombret, Marie Christine ^a,b,c,e,f   Knapp, Dominique ^a,b,c,f   Hamidi, Fatima ^a,b,c   Alavoine, Loubna ^e   Taillé, Camille ^a,b,c,e,f   Chanez, Pascal ^g   Erjefält, Jonas S ^d   Aubier, Michel ^a,b,c,e,f  

^a LabEx Inflamex   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Directrice de la Maison des adolescents de l'Hôpital Cochin   (France)

^d LUND UNIVERSITY   (Sweden)

^e BICHAT HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g AIX MARSEILLE UNIVERSITY   (France)

Author keywords

airway remodeling; airway smooth muscle; asthma control; bronchial epithelium; epithelium neuroendocrine cells; mucosal nerves; Refractory asthma

Indexed keywords

PREDNISONE;

ADULT; AGED; AIRWAY REMODELING; AIRWAY SMOOTH MUSCLE CELL; ARTICLE; ASTHMA; ASTHMA CONTROL TEST SCORE; ASTHMA QUALITY OF LIFE QUESTIONNAIRE; BASEMENT MEMBRANE; BRONCHIAL THERMOPLASTY DEVICE; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS EPITHELIUM; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OUTCOME; CORTICOSTEROID THERAPY; DEVICE SAFETY; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY WARD; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG BIOPSY; LUNG FUNCTION; MALE; MUCUS GLAND; NEUROSECRETORY CELL; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; REFRACTORY ASTHMA; RESPIRATORY TRACT DISEASE ASSESSMENT; SCORING SYSTEM; THERAPY EFFECT; BRONCHUS; CLINICAL TRIAL; LUNG FUNCTION TEST; MIDDLE AGED; PATHOLOGY; PROCEDURES; QUALITY OF LIFE; RADIATION RESPONSE; THERMOTHERAPY; TREATMENT OUTCOME;

ADULT; AGED; ASTHMA; BRONCHI; BRONCHOSCOPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 85006132133     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.08.009     Document Type: Article

References (36)

1. 1 Wener, R.R., Bel, E.H., Severe refractory asthma: an update. Eur Respir Rev 22 (2013), 227–235.
2. 2 Hambly, N., Nair, P., Monoclonal antibodies for the treatment of refractory asthma. Curr Opin Pulm Med 20 (2014), 87–94.
3. 3 Pavord, I.D., Korn, S., Howarth, P., Bleecker, E.R., Buhl, R., Keene, O.N., et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380 (2012), 651–659.
4. 4 Miranda, C., Busacker, A., Balzar, S., Trudeau, J., Wenzel, S.E., Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 113 (2004), 101–108.
5. 5 Wenzel, S., Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 18 (2012), 716–725.
6. 6 Chung, K.F., Adcock, I.M., How variability in clinical phenotypes should guide research into disease mechanisms in asthma. Ann Am Thorac Soc 10:suppl (2013), S109–S117.
7. 7 Baraldo, S., Turato, G., Bazzan, E., Ballarin, A., Damin, M., Balestro, E., et al. Noneosinophilic asthma in children: relation with airway remodelling. Eur Respir J 38 (2011), 575–583.
8. 8 Hirota, N., Martin, J.G., Mechanisms of airway remodelling. Chest 144 (2013), 1026–1032.
9. 9 Brightling, C.E., Gupta, S., Gonem, S., Siddiqui, S., Lung damage and airway remodelling in severe asthma. Clin Exp Allergy 42 (2012), 638–649.
10. 10 Cox, G., Thomson, N.C., Rubin, A.S., Niven, R.M., Corris, P.A., Siersted, H.C., et al. Asthma control during the year after BT. N Engl J Med 356 (2007), 1327–1337.
11. 11 Pavord, I.D., Cox, G., Thomson, N.C., Rubin, A.S., Corris, P.A., Niven, R.M., et al. Safety and efficacy of BT in symptomatic, severe asthma. Am J Respir Crit Care Med 176 (2007), 1185–1191.
12. 12 Castro, M., Rubin, A.S., Laviolette, M., Fiterman, J., De Andrade Lima, M., Shah, P.L., et al. Effectiveness and safety of BT in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 181 (2010), 116–124.
13. 13 Wahidi, M.W., Kraft, M., BT for severe asthma. Am J Respir Crit Car Med 185 (2012), 709–714.
14. 14 Dombret, M.C., Alagha, K., Boulet, L., Brillet, P.Y., Joos, G., Laviolette, M., et al. BT: a new therapeutic option for the treatment of severe, uncontrolled asthma in adults. Eur Respir Rev 134 (2014), 510–518.
15. 15 Pretolani, M., Dombret, M.C., Thabut, G., Knap, D., Hamidi, F., Debray, M.P., et al. Reduction of ASM mass by BT in patients with severe asthma. Am J Respir Crit Care Med 190 (2014), 1452–1454.
16. 16 Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43 (2014), 343–373.
17. 17 Juniper, E.F., O'Byrne, P.M., Guyatt, G.H., Ferrie, P.J., King, D.R., Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999), 902–907.
18. 18 Juniper, E.F., Svensson, K., Mork, A.C., Stahl, E., Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 99 (2005), 553–558.
19. 19 Juniper, E.F., Guyatt, G.H., Ferrie, P.J., Griffith, L.E., Measuring quality of life in asthma. Am Rev Respir Dis 147 (1993), 832–838.
20. 20 Benayoun, L., Druilhe, A., Dombret, M.C., Aubier, M., Pretolani, M., Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167 (2003), 1360–1368.
21. 21 Bergqvist, A., Andersson, C.K., Mori, M., Walls, A.F., Bjermer, L., Erjefält, J.S., Alveolar T-helper type-2 immunity in atopic asthma is associated with poor clinical control. Clin Sci (Lond) 128 (2015), 47–56.
22. 22 Mori, M., Andersson, C.K., Svedberg, K.A., Glader, P., Bergqvist, A., Shikhagaie, M., et al. Appearance of remodeled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease. Thorax 68 (2013), 521–531.
23. 23 Bergqvist, A., Andersson, C.K., Hoffmann, H.J., Mori, M., Shikhagaie, M., Krohn, I.K., et al. Marked epithelial cell pathology and leukocyte paucity in persistently symptomatic severe asthma. Am J Respir Crit Care Med 188 (2013), 1475–1477.
24. 24 Pavord, I.D., Thomson, N.C., Niven, R.M., Corris, P.A., Chung, K.F., Cox, G., et al. Safety of BT in patients with severe refractory asthma. Research in Severe Asthma Trial Study Group. Ann Allergy Asthma Immunol 111 (2013), 402–407.
25. 25 Wechsler, M.E., Laviolette, M., Rubin, A.S., Fiterman, J., Lapa e Silva, J.R., Shah, P.L., et al. Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 132 (2013), 1295–1302.
26. 26 Chakir, J., Haj-Salem, I., Gras, D., Joubert, P., Beaudoin, È.L., Biardel, S., et al. Effects of bronchial thermoplasty on airway smooth muscle and collagen deposition in asthma. Ann Am Thorac Soc 12 (2015), 1612–1618.
27. 27 Danek, C.J., Lombard, C.M., Dungworth, D.L., Cox, P.G., Miller, J.D., Biggs, M.J., et al. Reduction in airway hyperresponsiveness to methacholine by the application of RF energy in dogs. J Appl Physiol 97 (2004), 1946–1953.
28. 28 Miller, J.D., Cox, G., Vincic, L., Lombard, C.M., Loomas, B.E., Danek, C.J., A prospective feasibility study of BT in the human airway. Chest 127 (2005), 1999–2006.
29. 29 Bourdin, A., Neveu, D., Vachier, I., Paganin, F., Godard, P., Chanez, P., Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 119 (2007), 1367–1374.
30. 30 Vrugt, B., Wilson, S., Bron, A., Holgate, S.T., Djukanovic, R., Aalbers, R., Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 15 (2000), 1014–1022.
31. 31 Lee, L.Y., Yu, J., Sensory nerves in lung and airways. Compr Physiol 4 (2014), 287–324.
32. 32 van der Velden, V.H., Hulsmann, A.R., Autonomic innervation of human airways: structure, function, and pathophysiology in asthma. Neuroimmunomodulation 6 (1999), 145–159.
33. 33 Linnoila, R.I., Functional facets of the pulmonary neuroendocrine system. Lab Invest 86 (2006), 425–444.
34. 34 Weichselbaum, M., Sparrow, M.P., Hamilton, E.J., Thompson, P.J., Knight, D.A., A confocal microscopic study of solitary pulmonary neuroendocrine cells in human airway epithelium. Respir Res 6 (2005), 115–126.
35. 35 Adriaensen, D., Timmermans, J.P., Purinergic signalling in the lung: important in asthma and COPD?. Curr Opin Pharmacol 4 (2004), 207–214.
36. 36 Darcy, R.D., Doeing, D.C., Hogarth, D.K., Dugan, K., Naureckas, E.T., White, S.R., Airway inflammation after bronchial thermoplasty for severe asthma. Ann Am Thorac Soc 12 (2015), 1302–1309.